Hypercalcemia due to primary hyperparathyroidism or malignant disease. Evaluated by means of biochemical tests and the steroid suppression test.
The cortisone suppression test and some biochemical tests were evaluated in 13 patients with hypercalcemia due to primary hyperparathyroidism (PHP) and in 10 with hypercalcemia due to a malignant disease. The biochemical tests revealed that serum chloride was significantly raised in patients with PHP compared to patients with malignant diseases, whereas no differences were observed with regard to the serum values of corrected calcium, serum phosphate, chloride/phosphate ratio, HCO3-. Although serum values of parathyroid hormone were higher in patients with PHP, a consider-able overlap was observed between values in the two patient groups. Corrected serum calcium values were significantly suppressed during cortisone administration in patients with malignant disease compared to patients wit PHP, whereas prednisolone had no suppressive effect. The positive predictive value of the test was 80.0% and the negative predictive value 66.7%. We conclude that there is still no entirely reliable method to distinguish between hypercalcemia due to PHP or malignant disease.
D002118:Calcium / Q000097:blood; D002712:Chlorides / Q000097:blood; D003348:Cortisone / Q000031:analogs & derivatives / Q000494:pharmacology; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D006934:Hypercalcemia / Q000175:diagnosis / Q000209:etiology*; D006961:Hyperparathyroidism / Q000150:complications*; D008297:Male; D009369:Neoplasms / Q000150:complications*; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood
D002712:Chlorides; D010281:Parathyroid Hormone; D010710:Phosphates; D002118:Calcium; D003348:Cortisone